Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
about
The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular CarcinomaHIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumPathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis.Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis.The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma.The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.Transmembrane semaphorins: Multimodal signaling cues in development and cancer.Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.Sema4D knockdown in oligodendrocytes promotes functional recovery after spinal cord injury.Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
P2860
Q26764896-185851E9-6285-407F-8872-431D407A9F1AQ34198666-4C4D3623-7B36-4ABA-937A-E4B247547DEAQ35171434-88A49C02-179D-4E16-8B52-02F876E4D14CQ35625509-CF73B8CD-3B37-4E64-8D8E-9C6970F58866Q35763195-3A828CEC-D58C-458E-93E7-B3F634D012CFQ36039632-1C024125-6748-48E7-AB44-7FCBE5306016Q36489379-AE86FA24-F72F-4B86-938C-5BEEA42D1A0BQ36931508-0BDE7D1E-AB4F-4CFB-9AF7-DAFB12354ADDQ37302918-68E293EE-CB56-4F4F-A6B6-82E62DB30C65Q37509059-7D151A59-A104-42AA-8CDE-9352A6A83D8DQ37542451-E834C4EB-1205-4AB9-BC66-814958F3DAC9Q39171575-8969C606-082E-4BC8-A862-EF28DA70A225Q44323325-557BB39C-223A-4F85-A440-B95CAE5BECB4Q52655048-ADD68EE1-567F-407B-B4C6-B178EC9459C5Q53136378-3E0A3A8C-C67A-4EBB-90FD-E5D211A6043C
P2860
Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@ast
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@en
type
label
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@ast
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@en
prefLabel
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@ast
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@en
P2093
P2860
P356
P1476
Over-expression of semaphorin4 ...... in ovarian epithelial cancer.
@en
P2093
P2860
P304
13264-13274
P356
10.3390/IJMS131013264
P407
P577
2012-10-16T00:00:00Z